Drug intelligence / Profile preview

DENV-3-LVHC-State University of New York - Upstate Medical University

Development stage
Phase 1
Lead developer
Upstate Medical University
Modality
Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

DENV-3-LVHC (Dengue Virus-3 Live Virus Human Challenge) is a characterized strain of Dengue virus serotype 3, specifically strain CH53489, utilized in Controlled Human Infection Models (CHIM). Developed and managed by the State University of New York (SUNY) Upstate Medical University, this live virus preparation is used to safely induce a controlled dengue infection in healthy adult volunteers. The primary objective of using DENV-3-LVHC is to study the clinical progression, viral kinetics, and immunologic responses associated with dengue infection and reinfection. These studies provide essential data for the development of dengue vaccines and therapeutics, allowing researchers to evaluate efficacy and the correlates of protection in a controlled clinical environment.

Other names
Dengue virus 3 Live Virus Human ChallengeDengue subtype 3 Challenge Virus strain CH53489DENV-3 strain CH53489DENV3 strain CH53489DENV 3 strain CH53489

Beyond the preview

Go deeper on DENV-3-LVHC-State University of New York - Upstate Medical University.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DENV-3-LVHC-State University of New York - Upstate Medical University.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call